129 related articles for article (PubMed ID: 7504661)
1. Efficacy of anti-CD5 F(ab')2 and Fab' immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mice.
Kohn FR; Fishwild DM; Bernhard SL; Better M; Kung AH
Int J Immunopharmacol; 1993 Nov; 15(8):871-8. PubMed ID: 7504661
[TBL] [Abstract][Full Text] [Related]
2. Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.
Better M; Bernhard SL; Lei SP; Fishwild DM; Lane JA; Carroll SF; Horwitz AH
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):457-61. PubMed ID: 7678457
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an anti-CD5-ricin A chain immunoconjugate in an improved human peripheral blood lymphocyte--reconstituted severe combined immunodeficient mouse model.
Kohn FR; Fishwild DM; Kung AH
Int J Immunopharmacol; 1993 Aug; 15(6):695-709. PubMed ID: 7691766
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates.
Fishwild DM; Wu HM; Carroll SF; Bernhard SL
Clin Exp Immunol; 1994 Jul; 97(1):10-8. PubMed ID: 8033405
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
Fishwild DM; Aberle S; Bernhard SL; Kung AH
Cancer Res; 1992 Jun; 52(11):3056-62. PubMed ID: 1375534
[TBL] [Abstract][Full Text] [Related]
6. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
Tutt A; Stevenson GT; Glennie MJ
J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxin.
Siegall CB; Gawlak SL; Chin JJ; Zoeckler ME; Kadow KF; Brown JP; Braslawsky GR
Bioconjug Chem; 1992; 3(4):302-7. PubMed ID: 1390985
[TBL] [Abstract][Full Text] [Related]
8. Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia.
Flavell DJ; Warnes S; Noss A; Flavell SU
Cancer Res; 1998 Dec; 58(24):5787-94. PubMed ID: 9865737
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
10. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
Glennie MJ; McBride HM; Worth AT; Stevenson GT
J Immunol; 1987 Oct; 139(7):2367-75. PubMed ID: 2958547
[TBL] [Abstract][Full Text] [Related]
11. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
12. Selective antitumor effect of thioether-linked immunotoxins composed of gelonin and monoclonal antibody to alpha-fetoprotein or its F(ab')2 fragment.
Masuda K; Takahashi K; Hirano K; Takagishi Y
Tumour Biol; 1994; 15(3):175-83. PubMed ID: 7521059
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P
Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251
[TBL] [Abstract][Full Text] [Related]
14. Importance of the antigen-binding valency and the nature of the cross-linking bond in ricin A-chain conjugates with antibody.
Masuho Y; Kishida K; Saito M; Umemoto N; Hara T
J Biochem; 1982 May; 91(5):1583-91. PubMed ID: 7096308
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
[TBL] [Abstract][Full Text] [Related]
16. [The enhancement of cytolytic activity in lymphokine activated killer cells using bispecific F(ab')2].
Azuma A
Nihon Ika Daigaku Zasshi; 1991 Dec; 58(6):663-72. PubMed ID: 1663120
[TBL] [Abstract][Full Text] [Related]
17. Gelonin analogs with engineered cysteine residues form antibody immunoconjugates with unique properties.
Better M; Bernhard SL; Fishwild DM; Nolan PA; Bauer RJ; Kung AH; Carroll SF
J Biol Chem; 1994 Apr; 269(13):9644-50. PubMed ID: 8144553
[TBL] [Abstract][Full Text] [Related]
18. Increased lysis of patient CD10-positive leukemic cells by T cells coated with anti-CD3 Fab' antibody cross-linked to anti-CD10 Fab' antibody.
Oshimi K; Seto T; Oshimi Y; Masuda M; Okumura K; Mizoguchi H
Blood; 1991 Mar; 77(5):1044-9. PubMed ID: 1825287
[TBL] [Abstract][Full Text] [Related]
19. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
20. [High level expression of chimeric antibody fragment F(ab')2 directed against CD20 in Escherichia coli].
Xiong DS; Zheng MJ; Liu YX; Xu YF; Wang JH; Yang CZ
Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):673-8. PubMed ID: 15973988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
